
Kristen Jones, PharmD, discusses leadership strategies in pharmacy management that prioritize emotional intelligence and communication for enhanced team performance and patient care.
Kristen Jones, PharmD, discusses leadership strategies in pharmacy management that prioritize emotional intelligence and communication for enhanced team performance and patient care.
Pharmacy professionals evolve into strategic leaders, mastering emotional intelligence and management skills to navigate complex workplace dynamics and enhance patient care.
Kristen Jones, PharmD, discusses challenging traditional workplace paradigms by emphasizing the human element in pharmaceutical operations.
Kristen Jones, PharmD, discusses pharmacists as leaders at McKesson ideaShare 2025.
With the company’s dedication to providing crucial data for pharmacy stakeholders, IQVIA’s Lead Research Director Michael Kleinrock discussed the current trends in patients’ medication use.
Michael Murphy, PharmD, MBA, provided insights on his research regarding pharmacy deserts, who they impact the most, and the methods needed to improve them in the US.
In part 4 of our interview with Michael Kleinrock, lead director of research at IQVIA, he discussed how trends in medication use are currently impacting pharmacy businesses.
Michael Murphy, PharmD, MBA, discusses how the lack of a universal definition for pharmacy deserts is leading to a significant impact on patients’ access and outcomes.
Brooklyn Morgan, PharmD, discusses the transformation of pharmacy practice from a regulatory model to a more flexible approach.
Thomas Sherrer, PharmD, emphasizes teamwork and technology in inventory management to enhance patient safety and reduce medication errors.
Thomas Sherrer, PharmD, advocates for a team-driven, tech-enhanced approach to pharmacy inventory management, boosting patient care and operational efficiency.
Michael Kleinrock, lead director of research at IQVIA Institute for Human Data Science, discusses the current trends in medication use and where these drivers may be headed in the near future.
Brooklyn Morgan, PharmD, director of state policy at the National Alliance of State Pharmacy Associations, emphasizes the importance of making the pharmacist's voice heard.
Congressman Buddy Carter (R-GA) champions the PBM Reform Act of 2025, aiming to enhance drug price transparency and empower pharmacists in healthcare delivery.
Thomas Sherrer, PharmD, co-owner of Poole's Pharmacy, describes implementing multiple tracking methods to stay ahead of drug shortages.
Michael Kleinrock from IQVIA joined Drug Topics to discuss his company’s recently released report, Understanding the Use of Medicines in the US 2025.
Crystal Lennartz, president of Health Mart & Health Mart Atlas at McKesson, discusses challenges that independent pharmacies are facing in today's health care landscape.
Jeanine Singer, senior vice president of national and key accounts at McKesson, discusses the company's approach to empowering pharmacists and strengthening the community pharmacy ecosystem.
Through platforms like Health Mart Atlas, the company is providing pharmacies with tools to better understand their financial landscape.
Thomas Sherrer, PharmD, emphasizes the importance of a team-based approach to inventory control.
Buddy Carter, PBM, US Representative (R-GA), emphasizes the critical role of pharmacists, particularly during the COVID-19 pandemic, and advocates for provider status recognition.
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, joins Drug Topics to discuss her extensive background in managing patients’ insulin regimens.
With federal reform continuing to stall, Drug Topics caught up with Iowa State Representative Brett Barker, PharmD, to discuss how his state is regulating pharmacy benefit managers.
In part 3 of our interview with Iowa State Representative Brett Barker, PharmD, he discusses how legislation at the state level is gradually informing decisions at the federal level.
Brett Barker, PharmD, state representative in Iowa’s 51st District, joined Drug Topics to discuss significant implications and common misconceptions regarding Iowa’s new PBM bill.
Brett Barker, PharmD, State Representative in Iowa’s 51st District, discussed Senate File 383 and how it’s intended to impact Iowa pharmacies.
Health care professionals emphasize patient education and reliable information in the evolving vaccine recommendation landscape.
Kevin W. Cleveland, PharmD, urges evidence-based approaches to immunizations in an era of uncertainty.
Following his presentation at the American Diabetes Association’s 85th Scientific Sessions, Jon Easter caught up with Drug Topics to discuss the pharmacists’ role in diabetes management.
As state-level PBM reform heats up amid dire situations for many retail pharmacies, Walgreens Chief Pharmacy Officer Rick Gates joins Drug Topics to discuss ongoing industry challenges.